PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q May 7, 2024 10-Q
8-K May 7, 2024 8-K
CORRESP May 6, 2024
S-3/A May 6, 2024 S-3/A
CORRESP May 3, 2024
CORRESP May 1, 2024
ARS Apr 26, 2024 ARS
DEFA14A Apr 26, 2024 DEFA14A
DEF 14A Apr 26, 2024 DEF 14A
8-K Apr 10, 2024 8-K
4 Apr 8, 2024 PRIMARY DOCUMENT
4 Mar 4, 2024 PRIMARY DOCUMENT
4 Mar 4, 2024 PRIMARY DOCUMENT
4 Mar 4, 2024 PRIMARY DOCUMENT
4 Mar 4, 2024 PRIMARY DOCUMENT
4 Mar 4, 2024 PRIMARY DOCUMENT
4 Mar 4, 2024 PRIMARY DOCUMENT
UPLOAD Feb 21, 2024
S-3 Feb 16, 2024 S-3
S-8 Feb 16, 2024 S-8
10-K Feb 15, 2024 10-K
8-K Feb 15, 2024 8-K
SC 13G/A Feb 13, 2024 EXIT FILING
SC 13G/A Feb 12, 2024
SC 13G/A Feb 12, 2024 SC 13G/A
← Newer Page 6 of 16 · 389 filings Older →